A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether- Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
In: Clinical Infectious Diseases, Jg. 62 (2016-04-15), Heft 8, S. 964-971
Online
academicJournal
Zugriff:
Background. Artemisinins, which are derived from plants, are subject to risk of supply interruption due to climatic changes. Consequently, an effort to identify a new synthetic antimalarial was initiated. A fixed-dose combination of arterolane maleate (AM), a new synthetic trioxolane, with piperaquine phosphate (PQP), a long half-life bisquinoline, was evaluated in patients with uncomplicated Plasmodium falciparum malaria. Methods. In this multicenter, randomized, double-blind, comparative, parallel-group trial, 1072 patients aged 12-65 years with P. falciparum monoinfection received either AM-PQP (714 patients) once daily or artemether-lumefantrine (A-L; 358 patients) twice daily for 3 days. All patients were followed up until day 42. Results. Of the 714 patients in the AM-PQP group, 638 (89.4%) completed the study; of the 358 patients in the A-L group, 301 (84.1%) completed the study. In both groups, the polymerase chain reaction corrected adequate clinical and parasitological response (PCR-corrected ACPR) on day 28 in intent-to-treat (ITT) and per-protocol (PP) populations was 92.86% and 92.46% and 99.25% and 99.07%, respectively. The corresponding figures on day 42 in the ITT and PP populations were 90.48% and 91.34%, respectively. After adjusting for survival ITT, the PCR-corrected ACPR on day 42 was >98% in both groups. The overall incidence of adverse events was comparable. Conclusions. AM-PQP showed comparable efficacy and safety to A-L in the treatment of uncomplicated P. falciparum malaria in adolescent and adult patients. AM-PQP demonstrated high clinical and parasitological response rates as well as rapid parasite clearance. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether- Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
|
---|---|
Autor/in / Beteiligte Person: | Toure, Offianan Andre ; Valecha, Neena ; Tshefu, Antoinette K. ; Thompson, Ricardo ; Krudsood, Srivicha ; Gaye, Oumar ; Krishnamurthy Rao, Bappanaidu Hoigegudde ; Sagara, Issaka ; Bose, Tarit Kumar ; Mohanty, Sanjib ; Rao, Ballamudi Srinivas ; Anvikar, Anupkumar R. ; Mwapasa, Victor ; Noedl, Harald ; Arora, Sudershan ; Roy, Arjun ; Iyer, Sunil S. ; Sharma, Pradeep ; Saha, Nilanjan ; Jalali, Rajinder K. |
Link: | |
Zeitschrift: | Clinical Infectious Diseases, Jg. 62 (2016-04-15), Heft 8, S. 964-971 |
Veröffentlichung: | 2016 |
Medientyp: | academicJournal |
ISSN: | 1058-4838 (print) |
DOI: | 10.1093/cid/ciw029 |
Schlagwort: |
|
Sonstiges: |
|